Navigation Links
Pharmacyclics Reports Second Quarter 2014 Results
Date:7/31/2014

are.

For more information about these comprehensive patient access programs, call 1-877-877-3536 or visit www.IMBRUVICA.com.

IndicationsIMBRUVICA is a kinase inhibitor indicated for the treatment of patients with:

  • Mantle cell lymphoma (MCL) who have received at least one prior therapy. Accelerated approval was granted for this indication based on overall response rate. Improvements in survival or disease-related symptoms have not been established. Continued approval for this indication may be contingent upon verification of clinical benefit in confirmatory trials;
  • Chronic lymphocytic leukemia (CLL) who have received at least one prior therapy;
  • Chronic lymphocytic leukemia with 17p deletion
  • Important Safety InformationIMBRUVICA can cause serious side effects.  Warnings and Precautions include hemorrhage, infection, cyptopenias, atrial fibrillation, second primary malignancies, and embryo-fetal toxicity.

    The most common adverse reactions include diarrhea, neutropenia, anemia, fatigue, musculoskeletal pain, peripheral edema, upper respiratory tract infection, nausea, bruising, dyspnea, constipation, rash, abdominal pain, pyrexia, vomiting, and decreased appetite.

    For other important safety information, please see Full Prescribing Information at www.imbruvica.com.

    About PharmacyclicsPharmacyclics® is a biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify and control promising product candidates based on scientific development and admini
    '/>"/>

    SOURCE Pharmacyclics, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

    Related medicine technology :

    1. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014
    2. Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
    3. WuXi PharmaTech to Partner with Pharmacyclics
    4. Pharmacyclics Reports Third Quarter 2013 Results
    5. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
    6. Pharmacyclics Reports Second Quarter 2013 Results
    7. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
    8. Pharmacyclics Reports First Quarter 2013 Results
    9. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    10. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    11. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/17/2014)... OTEMR, Inc. , ONETOUCH EMR, 2.0 has achieved ONC ... the software is capable of supporting eligible providers with ... measures required to qualify for funding under the American ... certified on July 14, 2014 by ICSA Labs ... (ONC-ACB) and is compliant in accordance with applicable criteria ...
    (Date:9/17/2014)... , Sept. 17, 2014  Members of ... and Interventional Associates announced today that the ... to enhance its image sharing capabilities and provide ... any network failures. In addition, the Dicom Systems ... navigate disparate PACS systems to more effectively deliver ...
    (Date:9/17/2014)... , Sept. 17, 2014 Women everywhere ... infections are not only uncomfortable, they,re often also embarrassing ... plans. pH-D Feminine Health Support ( http://ph-defense.com ) is ... It is an all-natural, homeopathic product. ... common symptoms of vaginal infection. In many cases, the ...
    Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 2Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 3New Product from Vireo Systems: pH-D Feminine Health Support 2
    (Date:9/17/2014)... The Food and Drug Administration (FDA) has ... consider: , 1. The appropriate indicated ... 2. The potential for adverse cardiovascular outcomes associated ... ongoing, an informally-organized litigation group subcommittee prepared a presentation ... therapy. Among others, ZKB attorney Michelle L. Kranz and ...
    (Date:9/17/2014)... September 17, 2014 StartX , ... 12 companies raising rounds of funding at its Summer ... hundred investors and media, was the first such gathering ... next to the university. The presentations were delivered on ... to StartX-QB3 Labs, a 2,000 square foot life science ...
    (Date:9/17/2014)... 2014 Cadiz Laser Spa offers ... procedures to clients throughout Central Texas. The newest ... Collagen Induction Therapy. Using the revolutionary Rejuvapen micro-needling ... help clients correct a wide variety of skin ... and Cadiz Laser Spa is currently offering a ...
    (Date:9/17/2014)... News) -- Present-day Europeans are the descendants of ... to a new study. Previous research ... early European farmers. But, a new genetic analysis ... the descendants of Ancient North Eurasians. Nearly all ... ancestral group, researchers from Harvard Medical School said. ...
    (Date:9/17/2014)... Steven Reinberg HealthDay Reporter ... uncovered a key factor to explain why antibiotic-resistant bacteria can ... DNA called plasmids appear to be the culprit. They can ... and some carry a gene that makes bacteria drug-resistant, a ... carry an antibiotic-resistant gene to a class of antibiotic called ...
    Breaking Medicine News(10 mins):Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 4Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 5Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 6Health News:Revolutionary Collagen Induction Therapy is Now Available at Cadiz Laser Spa 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 3
    ... new study has revealed that women diagnosed with breast ... exercise , then they should continue exercising, for ... ,Ohio State University researchers analysed 500 women, who had ... and more specifically the intensity and amount of physical ...
    ... smoking, by finding that regular smokers may have a higher ... never smoke. ,The study also found that while smokers ... in short run, this risk declines to the level of ... other words, both completely smoke-free life style and successful smoking ...
    ... is the biggest environmental issue no one's talking about," regrets ... founder of the Work Less Party, a Vancouver-based initiative aimed ... "As a society, we're working exponentially hard to decrease sustainability ... antidepressants are on the rise," he says. ,Americans ...
    ... it doesnt have to be that way always. ... that they have successfully managed to reduce wrinkles ... vitamin A. ,Not only did the cream ... people revealed it boosted levels of important skin repair ...
    ... an otherwise bleak healthcare scenario has emerged a heartening ... IM injection manufactured by the US based Institute for ... its Model List for Essential Medicines. ,Paromomycin ... (VL), the worlds second most deadly parasitic disease after ...
    ... prefer not to talk about, yet sufferers will go to ... overactive bladder (OAB) and it's characterized by a sudden ... ,Now, to reduce the symptoms of OAB, an Emory ... ankle to better help control the bladder. ,"Known ...
    Cached Medicine News:Health News:Exercise may Help Breast Cancer Patients to Lead a Healthy Life 2Health News:Regular Smokers are at the Risk of Developing Depression 2Health News:Work Less to Sustain Planet Earth, Say Activists 2Health News:Work Less to Sustain Planet Earth, Say Activists 3Health News:Wrinkles can Be Really Ironed Out, Thanks to Vitamin A 2Health News:A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List 2Health News:A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List 3Health News:Stimulating the Ankle Can Help Patients With Overactive Bladder 2
    ... The Vitros ECi brings true ... to immunodiagnostic testing. Highly sensitive assays ... oncology and bone metabolism testing are ... under development. The Vitros ECi can ...
    ... is a flexible system that ... environments small hospitals, backup ... satellite locations. The Vitros 250 ... can be automated or placed ...
    ... an effort to improve on the ... toxicology, abused drugs, and immunosuppressants tests, ... which incorporates random access capabilities. Although ... undergone several important changes in the ...
    The IMx system is an automated analyzer designed to perform microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FPIA) and ion capture technologies....
    Medicine Products: